| abstract |
Disclosed herein are methods of treating and/or preventing hypertension, metabolic syndrome, and/or renal disease that involve the targeting of Fructokinase (ketohexokinase). Also disclosed herein are methods of screening for inhibitors of Fructokinase. Further disclosed herein are methods of formulating a prescriptive regimen for hypertension, metabolic syndrome, and/or renal disease that comprises evaluating the level of ketohexokinase activity in an individual. |